Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) EPS (Basic) (2016 - 2025)

Apyx Medical's EPS (Basic) history spans 16 years, with the latest figure at -$0.03 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 75.0% year-over-year to -$0.03; the TTM value through Dec 2025 reached -$0.27, up 59.7%, while the annual FY2025 figure was -$0.27, 59.09% up from the prior year.
  • EPS (Basic) reached -$0.03 in Q4 2025 per APYX's latest filing, up from -$0.05 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.03 in Q2 2023 to a low of -$0.28 in Q4 2023.
  • Average EPS (Basic) over 5 years is -$0.13, with a median of -$0.12 recorded in 2021.
  • Peak YoY movement for EPS (Basic): surged 81.25% in 2023, then plummeted 533.33% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at -$0.06 in 2021, then tumbled by 183.33% to -$0.17 in 2022, then crashed by 64.71% to -$0.28 in 2023, then soared by 57.14% to -$0.12 in 2024, then skyrocketed by 75.0% to -$0.03 in 2025.
  • Per Business Quant, the three most recent readings for APYX's EPS (Basic) are -$0.03 (Q4 2025), -$0.05 (Q3 2025), and -$0.09 (Q2 2025).